MedDataX Logo

Health Status Prior and Post Infection With Influenza or COVID 19: a Population Based Retrospective Analysis of 2016-2021

NCT ID: NCT05087355

Last Updated: 2021-10-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

440000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-01-01

Study Completion Date

2021-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overall project aim is to study outcomes after COVID-19 and influenza hospitalisation from 2016 - 2021 by retrieving data from the main social security carriers in Austria for the years 2010-2018

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid 19 Influenza

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Influenza

PCR or antigen test for Covid 19 or Inluenza

Intervention Type DIAGNOSTIC_TEST

PCR or antigen test for Covid 19 or Inluenza

Covid 19

PCR or antigen test for Covid 19 or Inluenza

Intervention Type DIAGNOSTIC_TEST

PCR or antigen test for Covid 19 or Inluenza

Control group

hospitalisation due to other disease (not influenza or Covid 19)

PCR or antigen test for Covid 19 or Inluenza

Intervention Type DIAGNOSTIC_TEST

PCR or antigen test for Covid 19 or Inluenza

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PCR or antigen test for Covid 19 or Inluenza

PCR or antigen test for Covid 19 or Inluenza

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with SARS
* Patients with Covid-19
* Patients after Covid-19
* Patients with influenza

Exclusion Criteria

* none
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Landesklinikum Sankt Polten

OTHER

Sponsor Role collaborator

Sicknessfund Burgenland (BGKK)

UNKNOWN

Sponsor Role collaborator

A.รถ. Krankenhaus St. Josef Braunau GmbH

OTHER

Sponsor Role collaborator

Medical University of Vienna

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hendrik Jan Ankersmit

Principal Investigator/Univ. Prof. , MD, MBA

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AUTCOV-INFLU-STUDY

Identifier Type: -

Identifier Source: org_study_id